Skip to main content
. 2021 Nov 8;9:766107. doi: 10.3389/fchem.2021.766107

TABLE 1.

Immune checkpoint inhibitory effects of the synthesized compounds on the gene expression of CTLA-4 and PD-L1.

Compound IC50 (μM) against CTLA-4 a IC50 (μM) against PD-L1 b
1 49 57
2a >50 >50
2b 36 37
2c >50 >50
2d >50 >50
2e 26 31
2f 36 23
2g >50 >50
2h >50 41
2i >50 46
2j >50 >50
3a 31 47
3b 18 20
3c 26 18
3d 21 21
3e 20 14
5 30 27
6 >50 42
7 39 25
12 18 9.0
13 18 8.7
a

On HEK293 cells transfected with pCTLA-4–luciferase.

b

On A549 cells transfected with pPD-L1–luciferase.